Document is current
Any future updates will be listed below
-
Authors
Pedersen, Tenna Remler http://orcid.org/0000-0003-0144-8977
Bach, Maiken Bayer Thode
Stougaard, Camilla Løkke
Gredal, Hanne
Rusbridge, Clare
Finnerup, Nanna Brix
Berendt, Mette
-
Funding
Funding for this research was provided by:
Copenhagen University
- License Information
-
More Information
Article History
Received: 20 September 2023
Accepted: 17 January 2024
First Online: 8 February 2024
Declarations
:
: The study was approved by the Ethical Committee of University of Copenhagen (file number 2014-5) and by the Danish Animal Experiments Inspectorate (license no. 2006/561–1145, 2012-15-2934-00700 and 2016-15-0201-01074).
: Not applicable.
: None of the data used in the present study has been published previously.
: NBF has received consultancy fees from Vertex, Novartis Pharma, NeuroPN, Nanobiotix, Neurvati, and Samiona, has undertaken consultancy work for Aarhus University with remunerated work for Biogen, Merz, and Confo Therapeutics, and has received grants from IMI2PainCare an EU IMI 2 (Innovative medicines initiative) public-private consortium and the companies involved are: Grunenthal, Bayer, Eli Lilly, Esteve, and Teva, outside the submitted work.
